Prognostic significance of interleukin-1a (il1a) RS1800857 genetic polymorphism in develop pulmonary sarcoidosis in residents of Karelia
- Authors: Malysheva I.E.1, Topchieva L.V.1, Tikhonovich E.L.2
-
Affiliations:
- Institute of Biology of the Karelian Research Centre of the Russian Academy of Sciences
- V.A. Baranov Republican Hospital
- Issue: Vol 13, No 5 (2023)
- Pages: 967-971
- Section: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/2220-7619/article/view/158899
- DOI: https://doi.org/10.15789/2220-7619-PSO-9635
- ID: 158899
Cite item
Full Text
Abstract
The relevance of the research problem is justified by insufficient knowledge of the mechanisms for genetic regulation of inflammatory immune response during granuloma formation and arising inflammation in pulmonary sarcoidosis. It is believed that development of inflammatory process and formation of sarcoid granulomas occurs in subjects with genetically determined sensitivity to the effects of an unidentified etiological agent(s). The complexity of determining a causative factor(s) is accounted for by a variety of clinical forms and manifestations of the disease as well as a role for multifaceted immunological events in the pathogenesis of this disease. The process of inflammation, its intensity, may depend, among other issues, on host genetic background. Both enhanced and lowered production of pro-inflammatory factors can be observed in carriers of certain combinations of gene allelic variants. This, in turn, may determine human susceptibility to emergence of pulmonary sarcoidosis as well as alter clinical characteristics of the disease course and magnitude of developing immune inflammatory response. It should also be noted that the genetic background differs in various ethnic groups. Therefore, genetic background and environmental cues, ethnicity, may account for differed disease prevalence and phenotype. In this regard, it is relevant to search for allelic gene variations that could act as prognostic markers for development and progression of pulmonary sarcoidosis as well as characterize the features of its course. The data on the relationship between the carriage of allelic gene variations and susceptibility to pulmonary sarcoidosis as well as the contribution of IL1A rs1800857 polymorphic variant to development, progression, and therapy of the disease remain sparse and often contradictory. The current study assessed a risk of lung sarcoidosis in the subjects of Russian descent of the Republic of Karelia. According to the results of the studies, a significant association (p < 0.001) between the indicated IL1A gene allelic polymorphism and pulmonary sarcoidosis was established, with a risk of its development increasing by 3.47-fold (95% CI 2.41–5.01) in carriers of the T allele (p < 0.001). Thus, the single nucleotide polymorphism rs1800857 in the IL1A gene is associated with the risk of developing lung sarcoidosis in the subjects of Russian descent of the Republic of Karelia.
Full Text
##article.viewOnOriginalSite##About the authors
Irina E. Malysheva
Institute of Biology of the Karelian Research Centre of the Russian Academy of Sciences
Author for correspondence.
Email: I.E.Malysheva@yandex.ru
ORCID iD: 0000-0003-3583-0218
Scopus Author ID: 6603823505
ResearcherId: A-5737-2014
PhD (Biology), Senior Researcher, Laboratory of Genetics, Institute of Biology
Russian Federation, PetrozavodskLudmila V. Topchieva
Institute of Biology of the Karelian Research Centre of the Russian Academy of Sciences
Email: topchieva67@mail.ru
ORCID iD: 0000-0001-8697-2086
PhD (Biology), Leading Researcher, Laboratory of Genetics
Russian Federation, PetrozavodskElla L. Tikhonovich
V.A. Baranov Republican Hospital
Email: tikhonovich.ella@mail.ru
ORCID iD: 0000-0002-5416-9536
PhD (Medicine), Head of the Respiratory Therapy Department
Russian Federation, PetrozavodskReferences
- Визель А.А., Гурылёва М.Э. Потенциальные инфекционные триггеры при саркоидозе // Клиническая микробиология и антимикробная химиотерапия. 2002. Т. 4, № 4. С. 313—324. [Vizel A.A., Gurileva M.E. Potential infectious triggers in Sarcoidosis. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy, 2002, vol. 4, no. 4, pp. 313–324. (In Russ.)]
- Громова А.Ю., Симбирцев А.С. Полиморфизм генов семейства IL-1 человека // Цитокины и воспаление. 2005. Т. 4, № 2. С. 1–12. [Gromova A.Yu., Simbirtsev A.S. Gene polymorphisms of interleukin-1 family cytokines. Tsitokiny i vospalenie = Cytokines and Inflammation, 2005, vol. 4, no. 2, pp. 1–12. (In Russ.)]
- Bonifazi M., Gasparini S., Alfieri V., Renzoni E. Pulmonary sarcoidosis. Semin. Respir. Crit. Care Med., 2017, vol. 38, no. 4, pp. 437–449. doi: 10.1055/s-0037-1603766
- Chen E., Moller D. Etiologic role of infectious agents. Semin. Respir. Crit. Care Med., 2014, vol. 35, no. 3, pp. 285–295. doi: 10.1055/s-0034-1376859
- Costabel U., Ohshimo S., Guzman J. Diagnosis of sarcoidosis. Curr. Opin. Pulm. Med., 2008, vol. 14, no. 5, pp. 455–461. doi: 10.1097/MCP.0b013e3283056a61
- Grunewald J. Genetics of sarcoidosis. Curr. Opin. Pulm. Med., 2008, vol. 14, no. 5, pp. 434–439. doi: 10.1097/MCP.0b013e3283043de7
- Grutters J., Sato H., Pantelidis P., Ruven H., McGrath D.,Wells A.,van den Bosch J., Welsh K., du Bois R. Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis., 2003, vol. 20, no. 1, pp. 20–27.
- Hutyrová B., Pantelidis P., Drábek J., Zůrková M., Kolek V., Lenhart K., Welsh K., Bois R., Petrek M. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 2002, vol. 165, no. 2, pp. 148–151. doi: 10.1164/ajrccm.165.2.2106004
- Khazim K., Azulay E., Kristal B., Cohen I. Interleukin 1 gene polymorphism and susceptibility to disease. Immunol. Rev., 2018, vol. 281, no. 1, pp. 40–56. doi: 10.1111/imr.12620
- Nishiwaki T., Yoneyama H., Eishi Y., Matsuo N., Tatsumi K., Kimura H., Kuriyama T., Matsushima K. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am. J. Pathol., 2004, vol. 165, no. 2, pp. 631–639. doi: 10.1016/S0002-9440(10)63327-5
- Oswald-Richter K.A., Beachboard D.C., Zhan X., Gaskill C.F., Abraham S., Jenkins C., Culver D.A., Drake W. Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis. Respir. Res., 2010, vol. 11, no. 1: 161. doi: 10.1186/1465-9921-11-161
- Oswald-Richter K.A., Culver D.A., Hawkins C., Hajizadeh R., Abraham S., Shepherd B.E., Jenkins C.A., Judson M.A., Drake W.P. Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect. Immun., 2009. vol. 77, no. 9, pp. 3740–3748. doi: 10.1128/IAI.00142-09
- Trevilatto P., Scarel-Caminaga R., Brito Junior R., Souza A., Sallum A., Line S. Polymorphisms in the IL-1a and IL-1b genes are not associated with susceptibility to chronic periodontitis in a brazilian population. Braz. J. Oral Sci., 2003, vol. 2, no. 7, pp. 348–352. doi: 10.20396/bjos.v2i7.8641716
- Vasakova M., Sterclova M., Kolesar L., Slavcev A., Skibova J., Striz I. Cytokine gene polymorphisms in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis., 2010, vol. 27, no. 1, pp. 70–75.
- Yamaguchi T., Costabel U., McDowell A., Guzman J., Uchida K., Ohashi K., Eishi Y. Immunohistochemical detection of potential microbial antigens in granulomas in the diagnosis of sarcoidosis. J. Clin. Med., 2021, vol. 10, no. 5: 983. doi: 10.3390/jcm10050983